All Updates

BISMARCK, N.D. –– For the more than 4,500 North Dakotans who will be diagnosed with cancer in 2025, medical prior authorization can delay treatment, increase stress, and have a negative impact on their care . The Senate Industry and Business Committee of the North Dakota Legislature today took a significant

La administración emitió una orden ejecutiva para reducir significativamente la fuerza laboral federal, la cual, junto con otras acciones ejecutivas hasta la fecha, pone en riesgo la investigación del cáncer y la innovación.

Está previsto que el Comité de Presupuesto del Senado presente su resolución presupuestaria esta semana, preparando el terreno para recortes significativos en el gasto discrecional para compensar el costo del paquete.

Volunteer advocates from across Utah, including cancer survivors, patients and caregivers, rallied at the state Capitol on Tuesday for ‘Cancer Action Day,’ an event hosted annually by the American Cancer Society Cancer Action Network (ACS CAN). Advocates gathered inside the capitol rotunda to meet with their state lawmakers and urge them to support policies that aid in the fight against cancer.

Cancer Advocates Gathered at the Statehouse Today to Say Kentucky Can and Must Do Better to Reduce the Burden of Tobacco on Kentuckians

Cancer Advocates Gathered at the Statehouse Today to Say Kentucky Can and Must Do Better to Reduce the Burden of Tobacco on Kentuckians

BOISE, Idaho – Idaho House Bill 138 would effectively repeal Medicaid expansion, which would put nearly 85,000 state residents at risk of losing their health care coverage, including cancer patients who rely on Medicaid for life-saving treatment. A similar bill introduced last year was met with aggressive opposition from more

Everyone has the right to breathe clean, smoke-free air regardless of where they live, work or play. That is why the American Cancer Society Cancer Action Network (ACS CAN) opposes House Bill 211.

Last month, the American Cancer Society (ACS) released its annual report on cancer facts and trends, which found that, between 2017 and 2021, New Jersey had the highest incidence of pancreatic cancer behind D.C. It also found that progress is lagging for pancreatic cancer with incidence and mortality both increasing, and the 5-year survival for 9 out of 10 people diagnosed with tumors in the exocrine pancreas sitting at just 8%. Despite the concerning data, local pancreatic cancer survivor Nick Pifani is optimistic and views a path forward, in part through expanded access to biomarker testing. He is calling on leaders to help to improve access to biomarker testing when Assembly Bill 4163 / Senate Bill 3098 come under consideration.